Cardiogenic Shock Management

Initial Assessment and Monitoring

The American College of Cardiology recommends immediate comprehensive assessment including ECG and echocardiography for all patients with suspected cardiogenic shock 3
The European Society of Cardiology suggests establishing invasive monitoring with arterial line for accurate blood pressure measurement and sampling 4, 3
Consider early invasive hemodynamic assessment with pulmonary artery catheter to identify the specific cardiogenic shock phenotype and guide therapy, as recommended by the American College of Cardiology 1, 2
The Society for Cardiovascular Angiography and Interventions (SCAI) recommends classifying severity using the 5-stage (A-E) classification system to guide treatment decisions 1

The European Society of Cardiology recommends performing fluid challenge (saline or ringer lactate, >200 ml/15-30 min) as first-line treatment if there are no signs of overt fluid overload 4
In AMI-related cardiogenic shock, the European Heart Journal recommends performing immediate coronary angiography (within 2 hours) with intent to revascularize 4, 5
For patients with SCAI stage C or D cardiogenic shock, the American College of Cardiology recommends initial stabilization with vasopressor therapy and mechanical ventilation before revascularization 1
For patients with SCAI stage E (end-stage) cardiogenic shock, the American College of Cardiology recommends considering palliative care consultation 1

The American College of Cardiology recommends norepinephrine as the preferred first-line vasopressor agent when mean arterial pressure needs pharmacologic support 1, 5
The American College of Cardiology recommends dobutamine (2-20 μg/kg/min) as the first-line inotropic agent to increase cardiac output 1, 5
The American College of Cardiology suggests that milrinone may be considered as an alternative to dobutamine, particularly in patients on beta-blockers, with similar outcomes in cardiogenic shock 1

For LV-dominant cardiogenic shock, the American College of Cardiology recommends considering dobutamine or milrinone to improve cardiac output 1, 6
For RV-dominant cardiogenic shock, the American College of Cardiology suggests considering agents that increase systemic afterload without increasing pulmonary vascular resistance (vasopressin, norepinephrine) to maintain RV perfusion 6
For biventricular cardiogenic shock, the American College of Cardiology recommends considering combination therapy tailored to hemodynamic parameters 6
For normotensive hypoperfusion, the American College of Cardiology suggests considering vasodilators such as nitroprusside to improve cardiac output by reducing afterload 6

The European Society of Cardiology recommends considering short-term mechanical circulatory support in refractory cardiogenic shock based on patient age, comorbidities, and neurological function 4
The European Heart Journal does not recommend routine use of intra-aortic balloon pump (IABP) in cardiogenic shock 4, 5
For RV failure, the American College of Cardiology recommends considering RV-specific mechanical support devices (Impella RP, Protek Duo) 6
For progressive pulmonary hypertension with RV failure, the American College of Cardiology suggests that venoarterial extracorporeal membrane oxygenation may be preferred 6

The American College of Cardiology recommends transferring patients with cardiogenic shock to a tertiary care center with 24/7 cardiac catheterization capability and mechanical circulatory support availability 1, 4
The American College of Cardiology suggests implementing a multidisciplinary shock team approach for complex cases 7
The American College of Cardiology recommends developing shock networks with regionalized systems of care to improve clinical outcomes 6

In cardiogenic shock due to valvular disease, the Anaesthesia journal recommends considering emergency cardiac surgery as the gold standard treatment 8
For arrhythmia-induced cardiogenic shock, the Anaesthesia journal prioritizes restoration of sinus rhythm 8
In atrial fibrillation with cardiogenic shock, the Anaesthesia journal recommends amiodarone as the most efficient and safest agent for cardioversion 8